NasdaqGM - Nasdaq Real Time Price USD

RxSight, Inc. (RXST)

Compare
37.58 -1.59 (-4.06%)
At close: December 11 at 4:00:00 PM EST
39.00 +1.42 (+3.78%)
Pre-Market: 5:04:18 AM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Ronald M. Kurtz M.D. President, CEO & Director 1.21M -- 1963
Mr. Eric J. Weinberg Co-President & Chief Commercial Officer 762.74k -- 1961
Ms. Shelley B. Thunen Co-President & Chief Financial Officer 762.22k -- 1954
Dr. Ilya Goldshleger Ph.D. Co-President & Chief Operating Officer 761.46k -- 1975
Ms. Rebecca Williston Vice President of Accounting & Finance -- -- --
Mr. Matt Haller Ph.D. Chief Technology Officer -- -- --
Mr. Oliver Moravcevic Vice President of Investor Relations -- -- --
Mr. Steve Everly Senior VP of Sales of North America -- -- --
Mr. Roy Freeman Senior VP of Marketing & Professional Relations -- -- --
Ms. Caroline Vaughn Vice President of Human Resources -- -- --

RxSight, Inc.

100 Columbia
Aliso Viejo, CA 92656
United States
949 521 7830 https://www.rxsight.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
374

Description

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Corporate Governance

RxSight, Inc.’s ISS Governance QualityScore as of December 1, 2024 is 6. The pillar scores are Audit: 4; Board: 5; Shareholder Rights: 8; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 7, 2024 at 9:05 PM UTC

RxSight, Inc. Earnings Date

Recent Events

November 8, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

November 7, 2024 at 9:30 PM UTC

Q3 2024 Earnings Call

November 7, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 22, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

September 5, 2024 at 7:45 PM UTC

at Wells Fargo Healthcare Conference

September 4, 2024 at 1:15 PM UTC

at Morgan Stanley Global Healthcare Conference

August 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 6, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 16, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

May 9, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers